LianBio (LIANY)

USD 0.26

(-0.04%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 1.32 Million 1 Million 525.69 Thousand 76.13 Thousand -
Gross Profit -1.32 Million -1 Million -525.69 Thousand -76.13 Thousand -
Operating Expenses 98.21 Million 124.19 Million 195.3 Million 135.02 Million 24.37 Million
Selling, General and Administrative Expenses 62.9 Million 64.51 Million 36.4 Million 13.93 Million 1.71 Million
Research and Development Expenses 35.31 Million 59.68 Million 158.9 Million 121.09 Million 22.66 Million
Other Expenses - 10.4 Million -455 Thousand 123 Thousand -
Cost and Expenses 99.54 Million 125.2 Million 195.82 Million 135.1 Million 24.37 Million
Operating Income -99.54 Million -125.2 Million -195.82 Million -135.1 Million -24.37 Million
Interest Expense - - - - -
Income Tax Expense 449.6 Thousand -332.6 Thousand 518.68 Thousand 4006.89 4006.89
Earnings before Tax 311.58 Million -110.49 Million -196.04 Million -139.84 Million -24.36 Million
Net Income 311.13 Million -110.15 Million -196.56 Million -139.84 Million -24.37 Million
Earnings Per Share Basic 2.88 -1.02 -1.83 -1.29 -0.23
Earnings Per Share Diluted 2.87 -1.02 -1.83 -1.29 -0.23
Weighted Average Shares Outstanding 107.91 Million 107.92 Million 107.27 Million 108.3 Million 108.3 Million
Weighted Average Shares Outstanding (Diluted) 108.34 Million 107.92 Million 107.27 Million 108.3 Million 108.3 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA 312.91 Million -109.48 Million -195.51 Million -134.9 Million -24.37 Million
Earnings Before Tax Margin - - - - -

Income Statement Charts